Erin Michael

BOSTON — Patients with metabolic dysfunction-associated steatotic liver disease who underwent bariatric surgery lost less weight over 5 years than those without MASLD, according to research presented at The Liver Meeting.“Individuals with MASLD at baseline lost less total weight,” Monica Tincopa, MD, MS, a gastroenterologist, transplant hepatologist and assistant professor of

BOSTON — Healio spoke with James L. Boyer, MD, FACEP, about interim results from the phase 2a INTEGRIS-PSC trial presented at The Liver Meeting, which showed bexotegrast reduced biomarkers of liver fibrosis vs. placebo.The ongoing phase 2 study is assessing bexotegrast in patients with primary sclerosing cholangitis and suspected liver fibrosis, and evaluating its safety, tolerability and

Healio spoke with Chakra Chaulagain, MD, about phase 3 PERSEUS trial results presented at ASH 2023.

In this Healio video, Uma Mahadevan, MD, director of the Colitis and Crohn’s Disease Center at the University of California, San Francisco, discusses new study results assessing the use of interleukin-23 inhibitors in ulcerative colitis.“This was a big year for the IL-23s, with respect to ulcerative colitis,” Mahadevan told Healio.

In this video, Naval Daver, MD, discusses a presentation on updates in immune and cellular therapy in acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting. Daver, professor and director of the Leukemia Research Alliance Program in the department of leukemia at The University of Texas MD Anderson Cancer Center, said that Marion Subklewe, MD, of Ludwig-Maximilians-University

Healio spoke with John Molina, MD, MEd, about research updates on the use of immunotherapy in leukemia from this year’s Society of Hematologic Oncology Annual Meeting.Molina, who is an associate staff clinician in the leukemia and myeloid disorders division at Cleveland Clinic, explained that “a lot of the talks were kind of focused on immunotherapy, as it’s the main focus in

SAN DIEGO — Patients with primary biliary cholangitis who were incomplete responders to obeticholic acid may still demonstrate improvement in inflammatory markers and fibrosis scores, according to research presented at The Liver Meeting.During his presentation, David W. Victor III, MD, associate professor of clinical medicine at Houston Methodist Hospital, noted the findings show

SAN DIEGO — A ketogenic diet may improve antitumor function through beta-hydroxybutyrate, according to early research presented in a plenary scientific session at the ASH Annual Meeting and Exposition. Marco Ruella, MD, assistant professor of medicine at University of Pennsylvania’s Perelman School of Medicine, and colleagues implanted diffuse large B-cell lymphoma tumors in

San Antonio Breast Cancer Symposium 2024 provided multiple updates in the field of HER2-positive breast cancer, including novel treatments, new treatment regimens and more.See Healio’s highlights in HER2-positive breast cancer coverage below:

In this Healio exclusive video, Lawrence F. Eichenfield, MD, discusses oral treatments available to pediatric and adolescent psoriasis discussed at Maui Derm 2025. “From a systemic agent standpoint, we’ve never had an oral agent approved for psoriasis,” Eichenfield, who is chief of pediatric and adolescent dermatology at Rady Children’s Hospital-San Diego and vice chair of